🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Last week’s PolyBio Spring Symposium featured updates on innovative research that is driving forward discoveries in infection-associated chronic illnesses. If you weren’t able to attend live, or want to watch a replay, the recording is now available: polybio.org/spring-2025-sy…

“Teams have started to link persistent pathogens to the Alzheimer’s disease process… the plaque could be an antimicrobial peptide,” said Dr. Proal on Adam Rinde, ND’s podcast. “If they put a herpes virus into a [neuronal] model, the Alzheimer’s plaque forms right around the virus.”

It was great to be a guest on this podcast. I discuss mechanisms by which persistent #infections can contribute to a wide range of chronic diseases. This includes the potential ability of viral, bacterial or other pathogens to “seed” Alzheimer’s plaque: open.spotify.com/episode/3asb8F…

Yes! And we are excited that a grant to PolyBio will allow more imaging, and gut biopsies analyzed for #SARS-CoV-2 RNA, to be performed on participants in this trial

We are seeking Long COVID participants for this PolyBio-supported Sirolimus (low-dose #rapamycin) trial. To learn more about the trial check out this talk by PolyBio Research Director Dr. Amy Proal. She overviews the trial design and rationale: m.youtube.com/watch?v=nzwH55…

Boston-area Long COVID, #MECFS, and Post-Treatment #Lyme patients: Come participate in our research study! You must have small fiber neuropathy diagnosed by a skin punch biopsy to participate. The study is working to uncover potential inflammatory, infectious, and blood

The VIPER program has huge potential, and this is a great summary! But to clarify - we are still in the process of getting VIPER fully funded by private donors. We have a slide deck on VIPER that can be shared with interested donors. Email [email protected] to inquire.